The Potential Benefits of HPV Vaccination in Previously Infected Women

by John T. Schiller
Published 2016-08-01

Chitosan-Poly (I:C)-PADRE Based Nanoparticles as Delivery Vehicles for Synthetic Peptide Vaccines

by Jorge F. Correia-Pinto, Noemi Csaba, John T. Schiller, Maria J. Alonso
Published 2015-09-01

Human papillomavirus type 16 entry: retrograde cell surface transport along actin-rich protrusions.

by Mario Schelhaas, Helge Ewers, Minna-Liisa Rajamäki, Patricia M Day, John T Schiller, Ari Helenius
Published 2008-01-01

Involvement of nucleophosmin (NPM1/B23) in assembly of infectious HPV16 capsids

by Patricia M. Day, Cynthia D. Thompson, Yuk Ying Pang, Douglas R. Lowy, John T. Schiller
Published 2015-12-01

Strain-specific properties and T cells regulate the susceptibility to papilloma induction by Mus musculus papillomavirus 1.

by Alessandra Handisurya, Patricia M Day, Cynthia D Thompson, Michael Bonelli, Douglas R Lowy, John T Schiller
Published 2014-08-01

Carrageenan is a potent inhibitor of papillomavirus infection.

by Christopher B Buck, Cynthia D Thompson, Jeffrey N Roberts, Martin Müller, Douglas R Lowy, John T Schiller
Published 2006-07-01

Efficient Production of Papillomavirus Gene Delivery Vectors in Defined In Vitro Reactions

by Carla Cerqueira, Cynthia D. Thompson, Patricia M. Day, Yuk-Ying S. Pang, Douglas R. Lowy, John T. Schiller
Published 2017-06-01

Entry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosis.

by Mario Schelhaas, Bhavin Shah, Michael Holzer, Peter Blattmann, Lena Kühling, Patricia M Day, John T Schiller, Ari Helenius
Published 2012-01-01

Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer

by Rim Hojeij, Sonia Domingos-Pereira, Marianne Nkosi, Dalila Gharbi, Laurent Derré, John T. Schiller, Patrice Jichlinski, Denise Nardelli-Haefliger
Published 2016-07-01

Large scale RNAi reveals the requirement of nuclear envelope breakdown for nuclear import of human papillomaviruses.

by Inci Aydin, Susanne Weber, Berend Snijder, Pilar Samperio Ventayol, Andreas Kühbacher, Miriam Becker, Patricia M Day, John T Schiller, Michael Kann, Lucas Pelkmans, Ari Helenius, Mario Schelhaas
Published 2014-05-01

Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles.

by Rhonda C Kines, Vladimir Zarnitsyn, Teresa R Johnson, Yuk-Ying S Pang, Kizzmekia S Corbett, John D Nicewonger, Anu Gangopadhyay, Man Chen, Jie Liu, Mark R Prausnitz, John T Schiller, Barney S Graham
Published 2015-01-01

Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica.

by Rolando Herrero, Wim Quint, Allan Hildesheim, Paula Gonzalez, Linda Struijk, Hormuzd A Katki, Carolina Porras, Mark Schiffman, Ana Cecilia Rodriguez, Diane Solomon, Silvia Jimenez, John T Schiller, Douglas R Lowy, Leen-Jan van Doorn, Sholom Wacholder, Aimée R Kreimer, CVT Vaccine Group
Published 2013-01-01

Comparison of antibody responses to human papillomavirus vaccination as measured by three assays

by Hilary Ann Robbins, Troy J Kemp, Carolina ePorras, Ana Cecilia eRodriguez, Mark eSchiffman, Sholom eWacholder, Paula eGonzalez, John eSchiller, Douglas eLowy, Sylviane ePoncelet, Mark eEsser, Katie eMatys, Allan eHildesheim, Ligia A Pinto, Rolando eHerrero, Mahboobeh eSafaeian
Published 2014-01-01